Enhanced glucose control for preventing and treating diabetic neuropathy
BC Callaghan, AA Little, EL Feldman… - … of systematic reviews, 2012 - cochranelibrary.com
BC Callaghan, AA Little, EL Feldman, RAC Hughes
Cochrane database of systematic reviews, 2012•cochranelibrary.comBackground There are two types of diabetes. Type 1 diabetes affects younger people and
needs treatment with insulin injections. Type 2 diabetes affects older people and can usually
be treated by diet and oral drugs. Diabetic neuropathy affects 10% of patients with diabetes
mellitus at diagnosis and 40% to 50% after 10 years. Enhanced glucose control is the best
studied intervention for the prevention of this disabling condition but there have been no
systematic reviews of the evidence. Objectives To examine the evidence for enhanced …
needs treatment with insulin injections. Type 2 diabetes affects older people and can usually
be treated by diet and oral drugs. Diabetic neuropathy affects 10% of patients with diabetes
mellitus at diagnosis and 40% to 50% after 10 years. Enhanced glucose control is the best
studied intervention for the prevention of this disabling condition but there have been no
systematic reviews of the evidence. Objectives To examine the evidence for enhanced …
Background
There are two types of diabetes. Type 1 diabetes affects younger people and needs treatment with insulin injections. Type 2 diabetes affects older people and can usually be treated by diet and oral drugs. Diabetic neuropathy affects 10% of patients with diabetes mellitus at diagnosis and 40% to 50% after 10 years. Enhanced glucose control is the best studied intervention for the prevention of this disabling condition but there have been no systematic reviews of the evidence.
Objectives
To examine the evidence for enhanced glucose control in the prevention of distal symmetric polyneuropathy in people with type 1 and type 2 diabetes.
cochranelibrary.com
